tiprankstipranks
Trending News
More News >

Susan Ringdal Insider Profile

4 Followers
Susan Ringdal, Vice-President at Hikma Pharmaceuticals, holds 115.98K shares in Hikma Pharmaceuticals (Ticker: GB:HIK).
tipranks
Susan Ringdal

Susan Ringdal
Hikma Pharmaceuticals (HIK)
Vice-President

Ranked #22,831 out of 103,225 Corporate Insiders

Profitable Transactions

64%
7 out of 11 Profitable Transactions

Average Return

+5.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

£2M
100.00%
A breakdown of Susan Ringdal's holdings

Insider Roles

Hikma Pharmaceuticals
(HIK)
Vice-President
Roles that Susan Ringdal holds in companies

Most Profitable Insider Trade

Stock:
Hikma Pharmaceuticals
(HIK)
Rating:Informative Sell
Date:May 17, 2021 - May 17, 2022
Return:+26.20%
The most profitable trade made by Susan Ringdal

Susan Ringdal's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Hikma Pharmaceuticals
Aug 13, 2025
Vice-President
Uninformative Sell
£2.14M
Success Rate for
HIK
7 out of 11 profitable transactions on
HIK
64%
Average Return for
HIK
Average return per transaction on
HIK
+5.70%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Mar 15, 2021
Uninformative Buy
£0.00
-
£0.00
May 17, 2021
Uninformative Buy
£0.00
-
£0.00
Mar 07, 2022
Uninformative Buy
£0.00
-
£0.00
Mar 15, 2022
Uninformative Buy
£0.00
-
£0.00
Apr 24, 2023
Uninformative Buy
£0.00
-
£0.00
List of latest transactions for each holding click on a transaction to see Susan Ringdal's performance on stock

Susan Ringdal insider profile FAQ

What is the percentage of profitable transactions made by Susan Ringdal?
The percentage of profitable transactions made by Susan Ringdal is 64%.
    What is the average return per transaction made by Susan Ringdal?
    The average return per transaction made by Susan Ringdal is 5.70%.
      What stocks does Susan Ringdal hold?
      Susan Ringdal holds: GB:HIK stocks.
        What was Susan Ringdal’s latest transaction?
        Susan Ringdal latest transaction was an Uninformative Sell of ―.
          What was Susan Ringdal's most profitable transaction?
          Susan Ringdal’s most profitable transaction was an Informative Sell of GB:HIK stock on May 17, 2021. The return on the trade was 26.20%.
            What is Susan Ringdal's role in Hikma Pharmaceuticals?
            Susan Ringdal's role in Hikma Pharmaceuticals is Vice-President.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.